Fra-2/AP-1 regulates melanoma cell metastasis by downregulating Fam212b
- 13 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 28 (4), 1364-1378
- https://doi.org/10.1038/s41418-020-00660-4
Abstract
Metastatic melanoma remains a challenging disease. Understanding the molecular mechanisms how melanoma becomes metastatic is therefore of interest. Herein we show that downregulation of the AP-1 transcription factor member Fra-2 in melanoma cells is associated with an aggressive melanoma phenotype in vitro and in vivo. In vitro, Fra-2 knockdown in melanoma cells promoted cell migration and invasion associated with increased Snail-1, Twist-1/2, and matrix metalloproteinase-2 (MMP-2) expression. In vivo, Fra-2 knockdown in a melanoma cell line led to increased metastasis into the lungs and liver. The increased metastatic potential of Fra-2 knockdown melanoma cells was likely due to an accelerated cell cycle transition and increased tissue angiogenesis. Using Fra-2 knockdown cell lines microarray analysis, we identified the protein Fam212b (family with sequence similarity 212 member B) as a downstream target of Fra-2. By additional knockdown of Fam212b in Fra-2 mutant cells, we mitigated the cell migration, invasion, and cell cycle transition phenotype induced by Fra-2 knockdown. Furthermore, Fam212b overexpression enhanced β-catenin pathway. Finally, Fam212b expression is correlated with increased melanoma metastasis and poor clinical outcomes in human patients. In summary, these findings reveal the Fra-2-Fam212b axis as a new pathway of melanoma metastasis, which can be in the future used as potential marker of the metastatic properties of melanoma.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (A01-CRC1811, B03811/1-6, B03811/1-7)
This publication has 41 references indexed in Scilit:
- HIF1α and HIF2α independently activate SRC to promote melanoma metastasesJCI Insight, 2013
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- GENT: Gene Expression Database of Normal and Tumor TissuesCancer Informatics, 2011
- The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cellsEuropean Journal of Cancer, 2010
- The Stem Cell-Associated Antigen CD133 (Prominin-1) Is a Molecular Therapeutic Target for Metastatic MelanomaThe International Journal of Cell Cloning, 2008
- Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma MetastasesMolecular Cancer Research, 2008
- The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasisBMC Medical Genomics, 2008
- A systems biology approach for pathway level analysisGenome Research, 2007
- Role of Fra-2 in breast cancer: influence on tumor cell invasion and motilityBreast Cancer Research and Treatment, 2007
- B16 as a Mouse Model for Human MelanomaCurrent Protocols in Immunology, 2000